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Summary Human foetal keratinocytes were transfected with a recombinant plasmid (pSV6-1) which
contained an origin defective SV40 genome. The resulting transformed cell line had many properties in
common with previously described SV40-transformed keratinocytes, including expression of simple epithelial-
type keratins. It was non-tumourigenic in nude mice at early passages, forming small benign cysts, however,
after approximately 46 in vitro passages, these transformed keratinocytes formed invasive squamous cell
carcinomas in athymic nude mice. Several in vitro changes were associated with this acquisition of
tumourigenicity (a) an alteration in cellular morphology, (b) development of a cytogenetically marked clone
and (c) loss ofcell surface fibronectin. The loss of fibronectin was also observed in vivo; cysts formed by SV6-1
Bam/HFK produced human fibronectin whereas tumours did not, although both tumours and cysts were
laminin- and keratin-positive. These results indicate that the spontaneous development of secondary events in
immortalised human cells may lead to the acquisition of a malignant phenotype.
Transformation of cells in vitro has for many years been
used as a model system to define the steps involved in
malignant transformation in vivo. In vitro transformation has
the advantage of allowing the effects of purified trans-
forming genes to be studied using defined target cells. Such
systems have, for instance, defined distinct classes of co-
operatively acting oncogenes (Land et al., 1983; Ruley,
1983). Rodent fibroblasts have been used in most of these
studies, but more recently human epithelial cells (from which
most human cancers arise) have been utilized. Trans-
formation of human epithelial cells has recently been
reviewed by Chang (1986).
The human epidermal keratinocyte system has become one
of the most important in vitro epithelial cell systems for the
study of cellular transformation, since their cultivation was
first reported by Rheinwald and Green (1975). In 1979,
Steinberg and Defendi showed that human epidermal
keratinocytes cultured by these methods could be
transformed by Simian virus 40 (SV40) (Steinberg &
Defendi, 1979). Since that date there have been several
investigations on the in vitro effects of SV40 on human
keratinocytes (Taylor-Papadimitriou et al., 1982; Banks-
Schlegel & Howley, 1983; Rhim et al., 1985). SV40 has been
shown to immortalise keratinocytes, to impair their ability to
follow the normal pathway to terminal differentiation, to
alter their response to tumour promoters, to decrease their
growth requirements in vitro and to induce several other
phenotypic alterations, including changes in keratin profiles,
the actin cytoskeleton and the extracellular matrix (Steinberg
& Defendi, 1979, 1985; Taylor-Papadimitriou et al., 1982;
Banks-Schlegel & Howley, 1983; Rhim et al., 1985;
Parkinson et al., 1983, 1984; Hronis et al., 1984; Bernard
et al., 1985; Banks-Schlegel & Rhim, 1986; Brown &
Parkinson, 1984; Edelman et al., 1985; Defendi et al., 1982).
Many of these changes produce a phenotype which is similar
to that expressed in vitro by keratinocytes derived from
human squamous cell carcinomas (SCCs) (Parkinson et al.,
1983, 1984; Rheinwald & Beckett, 1980, 1981; Rupniak et
al., 1985; Wu & Rheinwald, 1981; Brown & Parkinson,
1985). However, SV40 transformed human keratinocyte cell
lines have never been shown to be tumourigenic in vivo,
without a contribution from either another transforming
virus (Rhim et al., 1985) or the mutagenic effects of a
chemical carcinogen (Rhim et al., 1986).
In this paper we describe the establishment and some in
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vitro properties of an SV40-transformed human epidermal
keratinocyte cell line which undergoes spontaneous
progression to a malignant phenotype. Brief descriptions of
this line have appeared in some previous papers from this
laboratory (Parkinson et al., 1983, 1984; Brown &
Parkinson, 1984).
Materials and methods
Establishment ofthe cell line
Cultures of keratinocytes were derived from a sample of skin
from an 18-week old male human foetus, using the methods
of Rheinwald and Green (1975) as described previously
(Burnett & Gallimore, 1983).
For the production of SV40 transformants, foetal keratino-
cytes were plated at 2 xlIO cells per 9cm dish, with 3T3
feeder layers, in Dulbecco's modification of Eagle's medium
(DME), supplemented with 20% foetal bovine serum,
0.4pg ml- 1 hydrocortisone and 10ngml-1 cholera toxin.
When colonies had reached 4-8 cells in size, the 3T3 feeder
layers were removed with EDTA (Rheinwald & Green, 1975)
and the keratinocytes were transfected (Graham & van der
Eb, 1973) with Bam-HI linearised pSV6-1 DNA, an origin-
defective mutant of SV40 (Gluzman et al., 1980). After
transfection, fresh 3T3 feeder cells were added back. Rapidly
growing foci of compact epithelioid cells appeared in trans-
fected cultures, and were picked 4 weeks post-transfection.
These cells were then cultured in Joklik's medium,
supplemented with 10% foetal bovine serum, hydrocortisone
and cholera toxin. 3T3 feeder layers were used for the first
subculture but were unnecessary for subsequent subcultures
and in later passages hydrocortisone and cholera toxin could
be omitted. Subculturing was performed with trypsin-EDTA
at a split ratio of 1:3 for the first three passages and at 1:20
thereafter.
Tumourigenicity studies
Athymic (nude) mice were inoculated s.c. with 107 cells. For
histology, excised tumours or cysts were fixed in
formaldehyde/acetic acid/methanol (1:1:8 by vol.), embedded
in paraffin, sectioned and stained in haematoxylin and eosin
(H&E). For immunofluorescence, excised tumours were snap
frozen in liquid nitrogen, embedded in 'Tissue-tek' (Miles
Laboratories, Illinois, USA) and then 5 Hm cyrostat sections
were cut and picked up onto gelatin-coated slides, fixed in
acetone and air-dried.
For culturing tumour cells, the tissue was minced with
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scissors, digested in trypsin-EDTA and the cells were plated
out onto a 3T3 feeder layer (to inhibit the growth of mouse
fibroblasts) in Joklik's medium. Feeder layers were not used
in subsequent subcultures.
Cytogenetics
Metaphase preparations were made as previously described
(Gallimore & Richardson, 1973) except that colchicine was
added for 10min only. Preliminary cytogenetic analysis was
carried out using acetic/orcein stained chromosome
preparations. Giemsa-banded chromosomes were produced
as follows: Slides were incubated overnight at 60°C and then
washed for 10min in Hank's balanced salt solution. After
washing in pH 6.8 buffer (5 mM phosphate buffer tablets;
BDH Ltd., Poole, Dorset, UK), slides were immersed in
2.8% trypsin in pH 6.8 buffer for 50 sec at room
temperature. Slides were then rinsed in saline, stained for
4min in 0.04% Leishman in pH 6.8 buffer, and finally
washed in water, drained, and blotted dry.
Immunoblotting analysis ofkeratins
Cultured keratinocytes and samples of tumour tissue were
rinsed in cold PBS and then disrupted by sonication in
10mM tris-HCl pH 7.2, containing 0.15M NaCl and 1% (v/v)
Nonidet P-40 (NP40) at 0°C. This extract was then mixed
with an equal volume of 10mM tris-HCl pH 7.2, containing
1.25M NaCl and 1% NP40, and centrifuged at 10,000g for
5 min, then the pellet was washed in 10mM tris-HCl pH 7.2,
containing 0.7 M NaCl and 1% NP40, and dissolved by
boiling for 2 min in 50mM tris-HCl pH 6.8, containing 2%
(w/v) sodium dodecyl sulfate (SDS), 2% (v/v) 2-mercapto-
ethanol and 10% (v/v) glycerol. Aliquots containing 5 jg
protein (Geiger & Bessman, 1972) were electrophoresed on
7.5% SDS-polyacrylamide gels (Laemmli, 1970). Gels were
stained in Coomassie blue and then electrophoretically
transferred to nitrocellulose sheets as described by Jackson
and Thompson (1984). The nitrocellulose filters were next
soaked for 1 h at 37°C in 3% (w/v) bovine serum albumin
(BSA) in PBS, rinsed in PBS containing 0.1% (v/v) Tween 20
and then incubated for 1 h at 37°C in a 1 in 100 dilution of
AE1 or AE3 monoclonal antibody supernatant (Woodcock-
Mitchell et al., 1982), diluted in 3% BSA in PBS. The
monoclonal anti-keratin antibodies were a kind gift from Dr
T-T. Sun, Departments of Dermatology and Pharmacology,
New York University School of Medicine, New York 10016,
USA. Blots were then washed in PBS/Tween, incubated for
1 h at 370C in a 1 in 250 dilution (in BSA/PBS) of
biotinylated sheep anti-mouse immunoglobulin (Amersham
International, Amersham, UK), washed in PBS/Tween and
finally incubated for 30min at 37°C in a 1 in 500 dilution (in
BSA/PBS) of pre-formed streptavidin-biotinylated peroxidase
complexes (Amersham International). Blots were then washed
in PBS/Tween and stained bands were visualised by
incubation in PBS containing 0.5mgml-1 diaminobenzidine
and 0.03% H202.
Immunofluorescence
Cryostat sections were overlaid with primary antibodies
diluted in 1% (w/v) BSA in PBS and incubated for 1 h at
37°C. After extensive washing in PBS, sections were overlaid
with the appropriate fluorescein or rhodamine conjugated
species-specific second antibody (1/20-1/100; Serotec Ltd.,
Oxon UK) diluted in BSA/PBS and incubated for 30min at
37°C. Slides were then washed in PBS, mounted in 9 vol.
glycerol, 1 vol. PBS, pH 8.6, containing 25 g 1-1 1,4-diazabi-
cyclo-(2,2,2)-octane (Johnson et al., 1982) and examined
under incident light illumination with a Leitz Ortholux
microscope.
Primary antisera used were as follows: SV40 T-antigen;
serum from a rat carrying an SV40-induced tumour, keratin;
rabbit antiserum to human callous keratins (prepared by Dr
E.K. Parkinson and P.H. Gallimore in this department,
exactly as described by Sun and Green (1978)), fibronectin;
sheep antiserum to human plasma fibronectin (Serotec),
fibronectin, human; mouse monoclonal antibody to human
fibronectin (IST2; see Zardi et al., 1980) (Sera-Lab Ltd.,
Sussex, UK), laminin; rabbit antiserum to EHS sarcoma
laminin (Bethesda Research Laboratories, Bethesda, MD,
USA).
Results
Establishment ofthe cell line
Transfection of human foetal keratinocytes with DNA from
the origin-defective SV40 mutant pSV6-1 (Gluzman et al.,
1980) produced foci (4-10 transformants for 10,ug pSV6-1
per dish) of rapidly growing, morphologically altered
keratinocytes. One such focus was picked and designated
SV6-1 Bam/HFK. These cells established into a permanent,
apparently immortal cell line, without any noticeable crisis
phase; although terminal differentiation was observed in
colonies at early passages. The cell line has been
continuously subcultured for at least 212 passages (-916
population doublings); this is in contrast to the limited in
vitro lifespan (- 160 population doublings) of normal human
keratinocytes (Rheinwald & Green, 1977).
SV6-1 Bam/HFK keratinocytes showed far less stringent
growth requirements than normal keratinocytes, and after
initial early passages they required neither 3T3 feeder layers,
hydrocortisone, cholera toxin nor epidermal growth factor
for optimal growth.
The cells were all positive for SV40 T-antigen as shown by
immunofluorescence (Figure la) and SV40 T-antigens were
detected in immunoprecipitation and immunoblotting experi-
ments (data not shown).
Morphology ofthe transformed cells
Early passage cultures resembled normal keratinocytes in
morphology, although they appeared darker under phase
optics than normal keratinocytes and there was little
evidence of stratification and differentiation (Figure lb). At
about passage 12 (-60 population doublings) some hetero-
geneity became apparent in the cultures, with the appearance
of smaller more tightly packed cells, and at a low frequency,
some short fibroblastic cells. All cell types were SV40 T-
antigen positive. The minority fibroblastic cells, could be
removed by brief EDTA treatment (Rheinwald & Green,
1975) and this procedure was used to maintain cultures with
an epithelial morphology. As the cultures were passaged
further, the smaller epithelial cell type began to predominate,
so that at high passage levels ( -35-40) the cultures consisted
almost entirely of very small, tightly packed cells (Figure ic),
and this homogeneous morphology was maintained at all
further passages.
Cytogenetics
Between passage 3 and 20 the cell line was predominantly
pseudodiploid, but also contained a high proportion (-40%
metaphases) of polyploid cells. At this stage no cyto-
genetically marked clones were identified, but the majority of
cells were cytogenetically abnormal with dicentric and/or
ring chromosomes and chromosome translocation and
fragments. From this heterogeneous population a cyto-
genetically marked hyperdiploid clone was evident by
passage 47 (Table I). Three different isochromosomes
(markers 1, 3 and 4) were present in each pseudodiploid cell
and most cells also contained an acrocentric marker (marker
2) and a small abnormal metacentric marker (marker 5) as
illustrated as an insert to Figure 2. Haploidy for autosomes
7, 11, 15 and 18 and trisomy 3 was evident in most
metaphases of the clone. One chromosome 3 was abnormal
with a deletion from p22-pter. High quality G-bandedMALIGNANT PROGRESSION OF HUMAN CELLS IN VITRO
Figure 1 (a) SV40 T-antigen demonstrated in SV6-1 Bam/HFK
by indirect immunofluorescence using rat tumour-bearer serum.
Bar =20gm. x 500. (b) Phase contrast micrograph of SV6-1
Bam/HFK at passage 16. Bar=50gm. x 180. (c) Phase contrast
micrograph of SV6-1 Bam/HFK at passage 50. Bar=50gm.
x 180.
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karyotypes did not allow us to determine unequivocally the
chromosomal origins of the five marker chromosomes,
however, as can be seen in Figure 2, marker 1 may be
composed of the p arms of autosome 7. A retrospective
analysis identified one cell, after examining 37 G-banded cells
at passage 20, which had all of the five markers of the clone
described above. This indicates that at passage 20, approxi-
mately 2% of the SV6-1 Bam/HFK cells were related to the
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Figure 2 Giesma banded karotype of the clone observed in the SV6-1 Bam/HFK induced SCCs. The marker chromosomes
observed in SV6-1 Bam/HFK at passage 47, are shown in the insert.
clone predominating at passage 47. Additional cytogenetic
changes were identified in SV6-1 Bam/HFK cells following
SCC formation in nude mice (Table 1 and Figure 2). The
inverted chromosome 13, the isochromosome markers 3 and
4, and the small marker 5 were not retained, but 90% of the
cells were 3p-, -11, -17, -18 (or if diploid for 18 one
autosome had additional material on the q arms) plus
markers 1 and 2 (see Table I and Figure 2).
Tumourigenicity
At early passages SV6-1 Bam/HFK cells failed to form
tumours in athymic (nude) mice. They either formed small
disorganised cystic structures (
- 5 mm diameter) which
regressed after about 7 days, or more usually they produced
small keratinized cysts of similar size, which remained on the
animals for up to 2 months. Histological examination of such
cysts revealed that compared to normal foetal skin epidermis
(Figure 3b) more cell layers were evident, parabasal mitoses
were frequently observed, and the cells had irregular shaped
nuclei (Figure 3a). Keratohyalin granules and cornified
squames were seen at irregular intervals on the inner aspects
of these cysts, but no keratohyalin granules were observed in
foetal skin epidermis. These findings indicate that even at
early passage SV6-1 Bam/HFK cysts were slightly dysplastic.
At intermediate passage levels (20 to 35) SV6-1 Bam/HFK
cells still only formed benign cysts, but as passage number
increased there was a progressive development of a more
papillomatous histology (Table I).
At later passages (greater than 43), SV6-1 Bam/HFK cells
produced malignant tumours in 100% of nude mice.
Immediately after inoculation a small nodule formed, but
after a latent period of
- 4 weeks, large progressively
growing tumours formed which attained a diameter > 1 cm.
Histological examination of the tumours revealed groups of
tumour cells interspersed with connective tissue and in some
areas keratin 'pearls' formed (Figure 3c), which resembled
structures normally seen in human SCCs. At the edges of the
tumour it could be clearly seen that invasion was occurring
into surrounding mouse tissue e.g. muscle fibres (Figure 3d)
and an adjacent rib (Figure 3e). Invasion was also observed
macroscopically, since in some tumours the mouse epidermis
was breached, producing an ulcerated lesion, whilst in others
the tumours were found to be firmly attached to the chest
wall of the nude mouse, with invasion of intercostal muscles
and ribs.
When cells from the nude mouse tumours were re-
established in culture, they had a morphology which was
identical to that of the cells used for injection i.e. like that
shown in Figure ic. Furthermore their pattern of keratin
expression (see below), and karyotype (Figure 2 and Table I),
closely resembled the high passage cells. On re-inoculation
into nude mice these cells were found to be highly
tumourigenic with a tumour producing dose100 of less than
104 cells (Table I).
Keratins
As shown previously by others (Sun & Green, 1978), human
epidermis contained major keratins of apparent molecular
weight 67 Kd, 58 Kd, 56.5 Kd and 50 Kd and a small amount
of 48 Kd keratin, whereas cultured keratinocytes (from adult
skin) contained major 58 Kd, 56 Kd, 50Kd and 46 Kd
keratins and minor 52Kd, 48 Kd and 40Kd species (Figure
4a, lanes 1 and 2). The 56.5 Kd, 50Kd, 48 Kd and 40Kd
keratins were recognised by the AEI antibody and the
67 Kd, 58 Kd, 56 Kd and 52 Kd keratins were recognised by
AE3, but the 46Kd keratin was not recognised by either
antibody, in agreement with previous reports (Woodcock-
Mitchell et al., 1982; Eichner et al., 1984) (Figure 4b, c, lanes
1 and 2). Keratinocytes cultured from foetal skin had a
similar pattern to adult keratinocytes, except that they
expressed an additional 54Kd, AE3-positive keratin (Figure
4, lane 3).
Low-passage SV6-1 Bam/HFK keratinocytes produced
relatively less 58 Kd and 56 Kd keratins than normal
keratinocytes, practically undetectable levels of 50 Kd and
48 Kd keratins, and relatively increased levels of 54Kd and
52 Kd keratins (Figure 4, lane 4). High passage cells were
similar except that the 54 Kd keratin was absent (Figure 4,
lane 5). In samples from SV6-1 Bam/HFK induced tumours
(Figure 4, lane 6) the keratin pattern resembled that shown
by normal cultured keratinocytes (cf. lanes 2 and 3), except
that the tumour contained additional AEI-positive bands at
.-45 Kd and 55 Kd (Figure 4b, lane 6). In keratinocytes re-
cultured from tumour tissue, these additional AEI-positive
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Figure 3 (a) Section of a cyst formed in a nude mouse at 15 days after inoculation of SV6-1 Bam/HFK cells at passage 5. M =
mouse tissue, S=SV6-1 Bam/HFK cells. Bar=20jm. x525. (b) Section of skin from an 18 week-old human foetus. H&E.
Bar=20gm. x 525. (c) Section of tumour formed in nude mouse at 36 days after inoculation of SV6-1 Bam/HFK cells at passage
47. K =keratin pearl. H&E. Bar=20pm. x 525. (d) Same tumour as in (c), showing invasion of nude mouse striated muscle fibres
(M) by tumour cells (T). H&E. Bar=20,um. x 525. (e) Same tumour as in (c), showing invasion into base of a mouse rib (R) by
tumour cells (T). H&E. Bar=20 um. x 525.
bands did not persist (Figure 4b, lane 7) and the overall
keratin pattern resembled that of the high-passage cultured
SV6-1 Bam/HFK cells, except that the 50Kd keratin was
produced in larger amounts in the tumour cells (Figure 4,
lane 7).
The 46 Kd keratin, which was not detected by either AE1
or AE3 antibodies, was produced in all transformed and
tumour cells as shown by protein staining (Figure 4a, lanes 4
to 7).
Immunofluorescence staining ofcysts and tumours
In the cysts formed by low passage SV6-1 Bam/HFK keratino-
cytes, a band of SV40 T-antigen positive cells could be seen
(Figure 5a) which was keratin-positive (Figure 5b). These
cells were clearly producing human fibronectin, since the
same area was stained with the monoclonal antibody IST2
(Figure Sc); this antibody only recognises human, and not
mouse fibronectin (Zardi et al., 1980). The laminin antibody
used in these studies was raised against mouse (EHS
sarcoma) laminin, but cross-reacts with the human protein
(Brown & Parkinson, 1984). A simple stain with this antisera
was therefore insufficient to investigate whether laminin
might be being produced by the injected human keratino-
cytes, and a double-label procedure was therefore used to
stain both SV40 T-antigen and laminin on the same section.
This technique demonstrated that the T-antigen positive cells
in the cyst were closely associated with areas of laminin
staining (Figure Sd, e).
In the tumours, the double labelling method was used
throughout, since all the areas of tumour cells were inter-
spersed with mouse connective tissue. This staining showed
that the areas of keratin-positive tissue in the tumour were
indeed T-antigen positive SV6-1 Bam/HFK cells (Figure 6a,
b). These clusters of tumour cells were surrounded by areas
of fibronectin-containing tissue (Figure 6c, d), which must
have been mouse in origin, because no areas of the tumour
were stained with the monoclonal antibody IST2 (data not
shown). The islands of tumour cells were surrounded by an
almost continuous basement membrane-like pattern of
laminin staining (Figure 6e, f), but the tumour itself was not550 K.W. BROWN & P.H. GALLIMORE
The line went through no apparent 'crisis' period during its
establishment; (2) The line demonstrated decreased growth
1 2 3 4 5 6 7 requirements when compared with normal keratinocytes; (3)
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40 [191
The cells were less differentiated than normal keratinocytes,
as shown by their lack of stratification in vitro, their reduced
ability to undergo terminal differentiation when placed in
suspension (Parkinson et al., 1983, 1984), and their altered
response to tumour promoters (Parkinson et al., 1983, 1984);
(4) our SV40 transformed keratinocytes retained the ability
to produce extracellular matrix components, and at early
passage levels produced increased amounts of fibronectin
(Brown & Parkinson, 1984).
The pattern of keratin expression by the SV6-1 Bam/HFK
cells had features in common with previous reports. Firstly,
the transformants retained the expression of the keratins
b
56.5 [101
50 [14/15 r
48 [161
40 [19]
expressed by normal keratinocytes in vitro i.e. 58 Kd, 56 Kd,
50Kd, 48 Kd and 46 Kd as found for some other SV40
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al., 1985; Banks-Schlegel & Rhim, 1986), although expression
of the 48 Kd and 50Kd species was markedly reduced
(Figure 4). Secondly, as has been found by other
investigators (Taylor-Papadimitriou et al., 1982; Banks-
Schlegel & Howley, 1983; Hronis et al., 1984; Steinberg &
Defendi, 1985; Bernard et al., 1985; Banks-Schlegel & Rhim,
1986), the expression of keratins normally found in simple
epithelia (54Kd and 52Kd; Figure 4) was increased in our
SV40 transformed keratinocytes, although we could find no
significant difference in 40 Kd keratin expression between
normal and transformed cells (Figure 4). In the tumour, the
inntfArn of l-Arntin PsYr%recoinn rAncAvurPeml that nf patternll t)1 litinLl exprC;ssionl usIuiCy rtusmirUC; [LnkL 01
cultured keratinocytes (Figure 4) i.e. the tumour expressed a
'hyperproliferative' keratin pattern, as has been found in
c
67 [1]
58 [5]
56 [6]
54 [7]
52 [8]
Figure 4 Analysis of
Coomassie blue-stained
fractions. (b) Immunobl
keratin antibody. (c) Imn
Lane 1, adult epidermis; ]
3, cultured foetal keratin
passage 12; lane 5, SV(
tumour produced by SV6
recultured from SV6-1 Ba
polypeptides are identifie
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Discussion
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unique, we believe, but
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human SCCs (Weiss et al., 1984). On re-establishing the
tumour cells in vitro, the keratin pattern reverted to one
similar to that of cultured SV6-1 Bam/HFK cells, once again
emphasising how keratin expression is modulated by the
cell's external environment (Eichner et al., 1984; Fuchs &
Green, 1981; Doran et al., 1980). Although some
differentiation was evident in the tumour, demonstrated by
the production of keratin 'pearls' (Figure 3b), no 67 Kd
keratin (characteristic of fully keratinized epidermis (Eichner
et al., 1984)) was detected. This could have merely reflected
the very low level of differentiation as compared to normal
epidermis, or alternatively the area of tumour used for
human keratin polypeptides. (a) keratin analysis may have been particularly undifferentiated.
SDS-polyacrylamide gel of keratin Two novel AEl positive keratin bands (45 Kd and 55 Kd)
ot stained with AEI monoclonal anti- were detected in the tumour, but not in any of the cultured
nunoblot stained with AE3 monoclonal. cells (Figure 4).
lane 2, cultured adult keratinocytes; lane In this paper we have extended our previous in vitro
ocytes; lane 4, SV6-1 Bam/HFK cells at (Brown & Parkinson, 1984) studies of the keratinocyte
6-1 Bam/HFK at passage 48; lane 6, extracellular matrix to the in vivo situation Interestingly low 4-1 Bam/HFK at passage 48; lane 7, cells extracellular *marxt terinovyvo si Inrestingly,nlow Lm/HFK tumour. On the left the keratin passage SV6-1 Bam/HFK keratinocytes expressed fibronectln d by their apparent molecular weights in the cysts (Figure Sc), but no human fibronectin could be
square brackets indicate the probable detected in the SCC tumours formed by the high passage
s using the numerical nomenclature of cells (data not shown), although the tumours contained large
In and Green (1978). Dots in (b), lane 6, amounts of mouse fibronectin (Figure 6d). Thus the
45 Kd AEI-positive keratins. reduction in fibronectin production which occurs as SV6-1
Bam/HFK keratinocytes are passaged in vitro (Brown &
Parkinson, 1984) is maintained in vivo. In contrast, both high
nent membrane in any of the tumour and low passage cells synthesized laminin in vitro, and
ta not shown). although we could not definitively show production of
laminin by SV6-1 Bam/HFK keratinocytes in vivo (as no
human specific antibody was available) the close proximity of
T-antigen positive cells and areas of laminin staining in both
human epidermal keratinocyte cell the cysts (Figure Sd, e) and tumours (Figure 6e, f) suggests
[iS paper undergoes spontaneous that both the low- and high-passage cells may produce
ant phenotype, which makes this line laminin in vivo. Thus it appears that at least some basement
in many other respects it resembles membrane components are produced in SV6-1 Bam/HFK
V40 transformed keratinocyte lines induced nude mouse tumours, which is similar to the results
1979, 1985; Taylor-Papadimitriou et reported by Gusterson et al. (1984) for human SCCs.
1 & Howley, 1983; Rhim et al., 1985; The truly novel result of our work has been the finding
rnard et al., 1985; Banks-Schlegel & that after extensive passaging in vitro (corresponding to
t al., 1985; Defendi et al., 1982): (1) approximately 200 population doublings) SV6-1 Bam/HFK
a
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Figure 5 Indirect immunofluorescence of a nude mouse cyst formed by SV6-1 Bam/HFK at passage 17 (8 days post-inoculation).
(a) SV40 T-antigen; (b) Keratin; (c) Human fibronectin (IST2 monoclonal antibody). (d) and (e), double staining of the same field;
(d), SV40 T-antigen; and (e) Laminin. Bars= 100,um for (a-c). x 120 and 20gim for (d), (e). x 500.
keratinocytes formed malignant tumours when inoculated
into athymic (nude) mice. Similarly, it has been reported that
many SV40 transformed rodent cells require extensive
passaging before they become tumourigenic (Tevethia, 1980).
Several in vitro phenotypic changes were associated with the
development of malignant potential in SV6-1 Bam/HFK: (1)
An alteration in cellular morphology (Figure 1); (2)
Development of a cytogenetically marked stem cell line
(Table I); and (3) A reduction in fibronectin production
(Brown & Parkinson, 1984). These alterations could be
explained by the development of an altered subpopulation of
transformants with a selective growth advantage, which
eventually outgrew the non-malignant transformants.
Whether any of these changes in in vitro phenotype were a
cause or a consequence of the development of malignancy,
they clearly indicate that a second event (or more) had
occurred after the initial establishment of the cell line. This
second event could possibly have been a re-arrangement of
integrated viral sequences, although the lack of an origin of
replication in the SV6-1 DNA used (Gluzman et al., 1980)
means that the integrated viral sequences would be unable to
undergo any T-antigen directed replication that could
promote excision and re-integration of viral DNA. Indeed
Southern blotting data (Byrd & Gallimore, unpublished
data) have shown no major differences in the pattern of
integrated SV40 sequences between low- and high-passage
SV6-1 Bam/HFK cells (and additionally this confirms that
the squamous cell carcinomas were produced by SV6-1
Bam/HFK cells).
Other likely candidates for possible second events are the
activation of cellular proto-oncogenes and/or loss of gene
products capable of malignancy suppression. In particular
ras oncogenes have been implicated in the development of
epidermal malignancies (reviewed in Balmain, 1985) and
infection of mouse keratinocytes with ras-containing retro-
viruses has been shown to induce alterations in their
differentiation programme and growth factor requirements
(Yuspa et al., 1985; Weissman & Aaronson, 1985). In
addition Rhim et al. (1985) have recently demonstrated that
human keratinocytes immortalized with an adenovirus 12-
SV40 hybrid virus could then be converted to a malignant
phenotype by addition of Kirsten murine sarcoma virus, a
ras-containing virus. However, Rhim et al. (1986) have also
found that Ad 12-SV40 immortalised human keratinocytes
can become malignant after treatment with chemical
carcinogens in vitro, but in this case they found no evidence
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Figure 6 Indirect immunofluorescence of a nude mouse tumour formed by SV6-1 Bam/HFK at passage 47 (60 days post-
inoculation). (a), (c) and (e), SV40 T-antigen; (b) keratin; (d), fibronectin; (f), laminin. (a-b), (c-d) and (e-f) are pairs showing the
same fields double stained for T-antigen and keratin or fibronectin or laminin. Bars=20gm. x 500.
to suggest ras activation. We are now investigating whether
there is any evidence of ras gene activation in high passage
SV6-1 Bam/HFK cells. Spontaneous activation of the N-ras
proto-oncogene has been previously demonstrated following
in vitro cultivation of a human teratocarcinoma cell line
(Tainsky et al., 1984).
Previous reports have indicated that other SV40 trans-
formed human keratinocytes are non-tumourigenic (Chang,
1986; Banks-Schlegel & Howley, 1983; Hronis et al., 1984),
even though some have been shown to form short-lived
cysts which resembled human SCCs (Banks-Schlegel &
Howley, 1983). The development of malignancy in the SV6-1
Bam/HFK line required extensive in vitro passaging, and one
possibility is that other SV40 transformants have simply not
been passaged sufficiently to accumulate secondary events
necessary to produce malignancy. The difference in our line
is probably not due to the use of foetal keratinocytes since,
from a number of independently derived SV40 transformed
human keratinocyte cell lines from post-neonatal donors with
an inherited susceptibility to cancer, two eventually acquired
a malignant phenotype on passage (Gallimore, Stacey &
Taylor, unpublished data).
The evolution of a cytogenetically marked clonal
population was clearly a major feature of the progression of
SV6-1 Bam/HFK cells. Of the five marker chromosomes
identified in the high passage clone only markers 1 and 2
were retained in the nude mouse derived SCC lines.
Although we have been unable to identify unequivocally the
origins of these markers their retention in the tumours may
indicate that genes mapping on these abnormal markers
made a contribution to the genesis of a malignant phenotype.
In addition, the cytogenetic changes to autosomes 3 and 11
may also be of significance. A number of human tumours
have been shown to have deletions or re-arrangements of the
p arms of chromosome 3 similar to SV6-1 Bam/HFK (Figure
2), including tumours of epithelial origin (Yoshida et al.,
1985). Interestingly, Teysseir et al. (1986) recently showed
that in two renal cell carcinomas the deletion of 3p resultedMALIGNANT PROGRESSION OF HUMAN CELLS IN VITRO 553
in the interstial translocation of the proto-oncogene c-raf 1
from 3p 25 to 3p 14. At least two proto-oncogenes, c-Ha-ras 1
(llp 15, de Martinville & Franke, 1983) and c-ets ( llq 23-24
De Taisne et al., 1984) have been mapped to chromosome
11, as has the locus associated with Wilm's tumour (lip 13,
Koufos et al., 1984). Genetic change to the single copy of
chromosome 11 in the high passage SV6-1 Bam/HFK clone
at any of these genetic loci may have generated the
malignant phenotype. Saxon et al. (1986) have recently
shown that chromosome 11 can suppress the malignant
phenotype of HeLa cells. Clearly the possible involvement of
the loss of one copy of autosome 11 in the malignant
phenotype of SV6-1 Bam/HFK cell could be resolved by the
development of somatic cell hybrids between the fibroblast
hybrid ESH15(TI) and SV6-1 Bam/HFK SCC, in an analo-
gous manner to Saxon et al.
The results described in this paper, together with a
previous report (Tainsky et al., 1984) indicate that profound
genetic changes may occur spontaneously during the in vitro
cultivation of human cells, and therefore caution is indicated
in interpreting the results from so-called '2-stage' in vitro
models where multiple genes or agents have been used, since
conversion of SV6-1 transformed normal keratinocytes to a
malignant phenotype may have represented several
spontaneous events.
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